Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A404JF | ISIN: US8964385046 | Ticker-Symbol: TRB
Lang & Schwarz
25.06.25 | 07:00
0,510 Euro
-100,00 % -0,510
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TRINITY BIOTECH PLC ADR Chart 1 Jahr
5-Tage-Chart
TRINITY BIOTECH PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
0,5000,52025.06.

Aktuelle News zur TRINITY BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiTRINITY BIOTECH PLC - 6-K, Report of foreign issuer3
DiTrinity Biotech plc: Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation10
15.05.Trinity Biotech plc: Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update198DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable...
► Artikel lesen
04.04.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer5
21.03.Trinity Biotech files to sell 4.29M American Depositary Shares for holders9
TRINITY BIOTECH Aktie jetzt für 0€ handeln
14.03.Trinity Biotech receives Nasdaq non-compliance notice25
14.03.Trinity Biotech plc: Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement248DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable...
► Artikel lesen
13.03.Trinity Biotech plc: Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring - Appoints Barclays to Advise on Ongoing Strategic Realignment Process220DUBLIN and PORTLAND, Ore., March 13, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions...
► Artikel lesen
13.03.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer5
28.02.Trinity Biotech sichert sich 4 Millionen US-Dollar für CGM-Technologie-Wachstum6
28.02.Trinity Biotech secures $4m for CGM technology growth3
28.02.Trinity Biotech plc: Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology184DUBLIN, Ireland, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
► Artikel lesen
28.02.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer-
06.02.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer-
06.02.Trinity Biotech reports leap in CGM system accuracy2
06.02.Trinity Biotech vermeldet Durchbruch in der Genauigkeit des CGM-Systems5
06.02.Trinity Biotech plc: Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial225DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable...
► Artikel lesen
28.01.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer1
28.01.Trinity Biotech verkündet Durchbruch in CGM-Technologie16
28.01.Trinity Biotech announces breakthrough in CGM technology3
Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1